M. L. Celma

1.4k total citations
19 papers, 1.2k citations indexed

About

M. L. Celma is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, M. L. Celma has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in M. L. Celma's work include Virology and Viral Diseases (11 papers), Respiratory viral infections research (8 papers) and Peptidase Inhibition and Analysis (4 papers). M. L. Celma is often cited by papers focused on Virology and Viral Diseases (11 papers), Respiratory viral infections research (8 papers) and Peptidase Inhibition and Analysis (4 papers). M. L. Celma collaborates with scholars based in Spain, Germany and United Kingdom. M. L. Celma's co-authors include D. Vázquez, R.E. Monro, Rafael Fernández-Muñoz, Juan Carabaña, David Vázquez, Robin E. Monro, José M. Casasnovas, Volker ter Meulen, J. A. P. Earle and K. Baczko and has published in prestigious journals such as Nature, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

M. L. Celma

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. L. Celma Spain 14 750 388 283 223 157 19 1.2k
Rafael Fernández-Muñoz Spain 11 621 0.8× 137 0.4× 278 1.0× 181 0.8× 126 0.8× 16 793
Martien C. M. Poelen Netherlands 21 603 0.8× 396 1.0× 226 0.8× 686 3.1× 87 0.6× 43 1.3k
Martin H. Koldijk Netherlands 11 882 1.2× 356 0.9× 370 1.3× 363 1.6× 161 1.0× 14 1.3k
R. G. Marusyk Canada 15 295 0.4× 214 0.6× 154 0.5× 87 0.4× 178 1.1× 38 695
Luca D. Bertzbach Germany 18 426 0.6× 245 0.6× 347 1.2× 162 0.7× 157 1.0× 58 962
Karen L. Goldenthal United States 15 440 0.6× 295 0.8× 240 0.8× 186 0.8× 54 0.3× 30 892
Reiko Ohuchi Japan 16 907 1.2× 330 0.9× 259 0.9× 198 0.9× 145 0.9× 25 1.1k
Nella J. Nieuwkoop Netherlands 17 727 1.0× 272 0.7× 179 0.6× 652 2.9× 64 0.4× 26 1.1k
Louis-Marie Bloyet United States 15 275 0.4× 318 0.8× 744 2.6× 140 0.6× 83 0.5× 23 1.1k
Tatiana Betáková Slovakia 20 564 0.8× 269 0.7× 233 0.8× 220 1.0× 123 0.8× 49 962

Countries citing papers authored by M. L. Celma

Since Specialization
Citations

This map shows the geographic impact of M. L. Celma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. L. Celma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. L. Celma more than expected).

Fields of papers citing papers by M. L. Celma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. L. Celma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. L. Celma. The network helps show where M. L. Celma may publish in the future.

Co-authorship network of co-authors of M. L. Celma

This figure shows the co-authorship network connecting the top 25 collaborators of M. L. Celma. A scholar is included among the top collaborators of M. L. Celma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. L. Celma. M. L. Celma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Muñoz-Alía, Miguel Ángel, José M. Casasnovas, M. L. Celma, et al.. (2017). Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies. Virus Research. 236. 30–43. 6 indexed citations
2.
Muñoz-Alía, Miguel Ángel, Rafael Fernández-Muñoz, José M. Casasnovas, et al.. (2014). Measles virus genetic evolution throughout an imported epidemic outbreak in a highly vaccinated population. Virus Research. 196. 122–127. 20 indexed citations
3.
Santiago, César, M. L. Celma, Thilo Stehle, & José M. Casasnovas. (2009). Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nature Structural & Molecular Biology. 17(1). 124–129. 102 indexed citations
4.
Moreno, Ana, Alberto Moreno, Maria Jesús Pérez‐Elías, et al.. (2006). Syncytial giant cell hepatitis in human immunodeficiency virus–infected patients with chronic hepatitis C: 2 cases and review of the literature. Human Pathology. 37(10). 1344–1349. 16 indexed citations
5.
Fernández-Muñoz, Rafael, et al.. (1999). Epidemiología molecular del virus del sarampión. Revista Española de Salud Pública. 73(5). 605–608. 1 indexed citations
6.
Carabaña, Juan, et al.. (1998). Measles Virus Fusion Protein Is Palmitoylated on Transmembrane-Intracytoplasmic Cysteine Residues Which Participate in Cell Fusion. Journal of Virology. 72(10). 8198–8204. 40 indexed citations
7.
Rima, B. K., M. L. Celma, K. Baczko, et al.. (1997). Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture.. Journal of General Virology. 78(1). 97–106. 157 indexed citations
9.
Rota, Jennifer S., Janet L. Heath, Paul A. Rota, et al.. (1996). Molecular Epidemiology of Measles Virus: Identification of Pathways of Transmission and Implications for Measles Elimination. The Journal of Infectious Diseases. 173(1). 32–37. 144 indexed citations
10.
Rima, B. K., J. A. P. Earle, Robert Yeo, et al.. (1995). Temporal and geographical distribution of measles virus genotypes. Journal of General Virology. 76(5). 1173–1180. 126 indexed citations
12.
Celma, M. L. & Rafael Fernández-Muñoz. (1992). Measles virus gene expression in lytic and persistent infections of a human lymphoblastoid cell line. Journal of General Virology. 73(9). 2203–2209. 8 indexed citations
13.
Marcén, R., José A. Pascual, L. Orofıno, et al.. (1992). Hepatitis C virus infection in kidney transplant patients.. PubMed. 24(1). 87–8. 1 indexed citations
14.
Montalbán, Carlos, et al.. (1987). Visceral leishmaniasis as an opportunistic infection in the acquired immunodeficiency syndrome. Journal of Infection. 15(3). 247–250. 18 indexed citations
15.
Celma, M. L., David Vázquez, & Juan Modolell. (1972). Failure of fusidic acid and siomycin to block ribosomes in the pretranslocated state. Biochemical and Biophysical Research Communications. 48(5). 1240–1246. 12 indexed citations
16.
Celma, M. L., R.E. Monro, & D. Vázquez. (1971). Substrate and antibiotic binding sites at the peptidyl transferase centre of E. coli ribosomes: Binding of UACCA‐Leu to 50 S subunits. FEBS Letters. 13(4). 247–251. 72 indexed citations
17.
Celma, M. L., R.E. Monro, & D. Vázquez. (1970). Substrate and antibiotic binding sites at the peptidyl transferase centre of E. coli ribosomes. FEBS Letters. 6(3). 273–277. 107 indexed citations
18.
Monro, Robin E., M. L. Celma, & David Vázquez. (1969). Action of Sparsomycin on Ribosome-catalysed Peptidyl Transfer. Nature. 222(5191). 356–358. 95 indexed citations
19.
Monro, R.E., T. Staehelin, M. L. Celma, & D. Vázquez. (1969). The Peptidyl Transferase Activity of Ribosomes. Cold Spring Harbor Symposia on Quantitative Biology. 34(0). 357–368. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026